Can myocardial work indices contribute to the exploration of patients with cardiac amyloidosis?
Male
Ventricular Function, Left
03 medical and health sciences
0302 clinical medicine
Predictive Value of Tests
Diseases of the circulatory (Cardiovascular) system
Humans
Heart Failure and Cardiomyopathies
Aged
Retrospective Studies
Aged, 80 and over
Observer Variation
Reproducibility of Results
Stroke Volume
Amyloidosis
Middle Aged
Prognosis
Myocardial Contraction
Echocardiography, Doppler
3. Good health
RC666-701
Exercise Test
Female
Cardiomyopathies
Echocardiography, Stress
DOI:
10.1136/openhrt-2020-001346
Publication Date:
2020-10-13T21:05:59Z
AUTHORS (10)
ABSTRACT
Background Cardiac amyloidosis (CA) is a life-threatening restrictive cardiomyopathy. Identifying patients with poor prognosis essential to ensure appropriate care. The aim of this study was compare myocardial work (MW) indices standard echocardiographic parameters in predicting mortality among CA. Methods Clinical, biological and transthoracic were retrospectively compared 118 Global index (GWI) calculated as the area left ventricular pressure–strain loop. efficiency (GWE) defined percentage ratio constructive sum wasted works. Sixty-one (52%) performed cardiopulmonary exercise. Results GWI, GWE, global longitudinal strain (GLS), ejection fraction (LVEF) contraction (MCF) correlated N-terminal prohormone brain natriuretic peptide (R=−0.518, R=−0.383, R=−0.553, R=−0.382 R=−0.336, respectively; p<0.001). GWI GLS peak oxygen consumption (R=0.359 R=0.313, p<0.05). Twenty-eight (24%) died during median follow-up 11 (4–19) months. best cut-off values predict all-cause for GLS, LVEF MCF 937 mm Hg/%, 89%, 10%, 52% 15%, respectively. under receiver operator characteristic curve 0.689, 0.631, 0.626, 0.511 0.504, Conclusion In CA population, MW are well known markers better than mortality. However, does not perform GLS.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (30)
CITATIONS (23)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....